A diagnosis that could shape your future might be resting on outdated rules. For decades, the key number used to flag a ...

For healthcare organizations, this standardized data opens new possibilities for research databases and real-world evidence platforms, potentially creating additional revenue streams from previously ...

The Agency is requesting additional confirmatory clinical evidence before a decision can be made. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Telix ...

It was determined that the capivasertib combination was unlikely to meet the 2 endpoints vs the comparator arm. AstraZeneca has made the decision to end the CAPItello-280 trial evaluating ...

Patients with smaller stage 1 human epidermal growth factor receptor 2 (HER2)-positive breast cancer had good outcomes whether or not they received chemotherapy. Outcomes were better, however ...

“There were studies done in 2004 that supported this approach, and it’s been sort of static since that time.” Immune checkpoint inhibitors had previously been investigated in HNSCC along ...

"Therapy for small, node-negative, HER2-positive breast cancer can be challenging due to the risk of overtreatment. Our study can help assess outcomes of patients according to specific tumor sizes ...

A Pacemaker to Control BP Gets FDA Breakthrough Designation The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering repeated ...

In order to make the systems "MRI-conditional," components have been redesigned to minimize the energy induced and discharged that is caused by the static, gradient, and combined field effects.

Heart failure is a pathological condition in which the heart is unable to pump enough blood to the rest of the body, because it is either unable to fill with a sufficient volume of blood or unable ...